Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Simarmata

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plos One|March 3, 2010
HLA class I restriction as a possible driving force for Chikungunya evolutionJoo Chuan Tong, Diane Simarmata, Raymond T P Lin, et al.
BMC Genomics|December 15, 2010
SVM-based prediction of linear B-cell epitopes using Bayes Feature ExtractionLawrence J K Wee, Diane Simarmata, Yiu-Wing Kam, et al.
Plos One|April 24, 2014
Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine developmentYiu-Wing Kam, Wendy W L Lee, Diane Simarmata, et al.
The Journal of Infectious Diseases|March 6, 2012
Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protectionYiu-Wing Kam, Diane Simarmata, Angela Chow, et al.
Journal of Virology|August 19, 2016
The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase SignalingFinny S Varghese, Bastian Thaa, Siti Naqiah Amrun, et al.
Journal of Virology|September 28, 2012
Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine developmentYiu-Wing Kam, Wendy W L Lee, Diane Simarmata, et al.
Scientific Reports|May 17, 2016
Early clearance of Chikungunya virus in children is associated with a strong innate immune responseDiane Simarmata, David Chun Ern Ng, Yiu-Wing Kam, et al.
EMBO Molecular Medicine|March 6, 2012
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoproteinYiu-Wing Kam, Fok-Moon Lum, Teck-Hui Teo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|March 3, 2010
HLA class I restriction as a possible driving force for Chikungunya evolutionJoo Chuan Tong, Diane Simarmata, Raymond T P Lin, et al.
BMC Genomics|December 15, 2010
SVM-based prediction of linear B-cell epitopes using Bayes Feature ExtractionLawrence J K Wee, Diane Simarmata, Yiu-Wing Kam, et al.
Plos One|April 24, 2014
Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine developmentYiu-Wing Kam, Wendy W L Lee, Diane Simarmata, et al.
The Journal of Infectious Diseases|March 6, 2012
Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protectionYiu-Wing Kam, Diane Simarmata, Angela Chow, et al.
Journal of Virology|August 19, 2016
The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase SignalingFinny S Varghese, Bastian Thaa, Siti Naqiah Amrun, et al.
Journal of Virology|September 28, 2012
Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine developmentYiu-Wing Kam, Wendy W L Lee, Diane Simarmata, et al.
Scientific Reports|May 17, 2016
Early clearance of Chikungunya virus in children is associated with a strong innate immune responseDiane Simarmata, David Chun Ern Ng, Yiu-Wing Kam, et al.
EMBO Molecular Medicine|March 6, 2012
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoproteinYiu-Wing Kam, Fok-Moon Lum, Teck-Hui Teo, et al.
Pageof 1